Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes. Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage ...
"Industry" burned a lot of things to the ground in Season 3, so a recap of all the chaos is almost a requirement before Season 4.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback